Albemarle ALB Specialties — Adjusted EBITDA
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Albemarle in its filing.
Tagged under the XBRL concept alb:AdjustedEBITDA.
The official record: Albemarle’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Albemarle's specialties — adjusted ebitda.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Albemarle's specialties — adjusted EBITDA?
- Albemarle (ALB) reported specialties — adjusted EBITDA of $76.13M in Q1 2026.
- How has Albemarle's specialties — adjusted EBITDA changed year-over-year?
- Albemarle's specialties — adjusted EBITDA increased by 29.8% year-over-year, from $58.67M to $76.13M.
- What is the long-term trend for Albemarle's specialties — adjusted EBITDA?
- Over 4 years (2021 to 2025), Albemarle's specialties — adjusted EBITDA has grown at a -12.4% compound annual growth rate (CAGR), from $468.84M to $275.74M.
- What does specialties — adjusted EBITDA mean?
- Measures the operational profitability of the Specialties segment by adding back depreciation, amortization, and other non-cash or non-recurring items to operating income. It is the primary metric used to evaluate the segment's cash-generating capability.